Literature DB >> 30926917

Comparison of multifrequency bioimpedance measured lean mass to that calculated from anthropomometric measurements in patients with chronic kidney disease.

Sarju Raj Singh Maharjan1, Keruo Jiang2, Adrian Slee3, Andrew Davenport4.   

Abstract

Patients with chronic kidney disease (CKD) are at increased risk of sarcopenia. Previous studies have proposed equations to estimate muscle mass based on triceps skin-fold thickness and mid-upper arm circumference, with or without adjustment for hand grip strength (HGS). We wished to evaluate their usefulness compared to multifrequency segmental bioimpedance (MFBIA) measured appendicular lean mass (ALM). We audited 160 CKD patients attending outpatient clinics, 65.6% male, median age 73 (62-81.5) years. We calculated muscle mass using six proposed equations based on anthropometric measurements. These equations over estimated muscle mass compared to MFBIA with a mean bias ranging from 3.4 to 35.9 kg. Apart from one equation, there was a systematic bias, with bias increasing with increasing fat mass (ranging from r = 0.17, p = 0.044 to r = 0.65, p < 0.001). For CKD patients we found that most of the previously proposed equations based on anthropometric equations over-estimated muscle mass compared to MFBIA.

Entities:  

Year:  2019        PMID: 30926917     DOI: 10.1038/s41430-019-0415-z

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  2 in total

1.  Application of the Clinical Frailty Score and body composition and upper arm strength in haemodialysis patients.

Authors:  Andrew Davenport
Journal:  Clin Kidney J       Date:  2021-11-23

2.  The disparity of measuring bone mineral content using bioimpedance and dual-energy absorptiometry in the context of hyperparathyroidism.

Authors:  Shirley Ferraz Crispilho; Eduardo Jorge Duque; Kalyanna Soares Bezerra; Rosa Maria R Pereira; Vanda Jorgetti; Rosilene M Elias; Rosa M A Moysés
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.